Y. Cai, J.-Y. Wang, and C. Bai, “Clinical Studies on conformal radiotherapy combined with epidermal growth factor receptor-tyrosine kinase inhibitor in second-line treatment of non-small cell lung cancer”, Trop. J. Pharm Res, vol. 15, no. 5, pp. 1053–1060, May 2016.